Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.920
+0.080 (2.08%)
At close: Sep 25, 2026, 4:00 PM EDT
3.963
+0.043 (1.10%)
After-hours: Sep 25, 2026, 6:48 PM EDT
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $245.99 million as of September 25, 2026. Its market cap has increased by 88.23% in one year.
Market Cap
245.99M
Enterprise Value
161.97M
1-Year Change
88.23%
Ranking
Category
Stock Price
$3.92
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $245.99M, an increase of 17.95%. That is a compound annual growth rate of 8.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 245.99M | -22.65% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 247.99M |
| Pyxis Oncology | 243.55M |
| Yarrow Bioscience | 242.56M |
| MacroGenics | 242.06M |
| ProQR Therapeutics | 241.32M |
| Lineage Cell Therapeutics | 239.71M |
| Cue Biopharma | 238.64M |
| Sionna Therapeutics | 236.46M |